Following the major breakthroughs in the and frequent and thorough exchange of treatment of acute leukemias in the seven- information. Hence, it was felt that a spe- ties by the introduction of intensive combi- cial series of symposia should be devoted to nation regimens, therapeutic progress has "Pharmacokinetics and Management of slowed down and the impression of stagna- Relapsed and Refractory Disease" comple- menting the established meetings on "Prog- tion may even have occured. In contrast, the knowledge about the biology of leu- nostic Factors and Treatment Strategies" kemias is rapidly expanding and allows new which will proceed in parallel. It was the insights into the pathophysiology of the aim of the international symposium disease. Further improvements also come "ACUTE LEUKEMIAS - Pharmacokine- from a better understanding of the pharma- tics and Management of Relapsed and cokinetics and pharmacodynamics of cyto- Refractory Disease" to provide an update static drugs and their mechanisms of action. of the present knowledge in this area and to Hence, novel treatment modalities can be stimulate further developments. As a sign developed on a more solid basis and ration- for the closing distance between countries al. These achievements need to be comple- and the development of effective world- mented by effective eradiation wide cooperation this symposium emerged of residual disease or its permanent control and new from the joint efforts of the German AML approaches have been derived from recent Cooperative Group and the M. D.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 20185366-n
Quantité disponible : Plus de 20 disponibles
Vendeur : BargainBookStores, Grand Rapids, MI, Etats-Unis
Paperback or Softback. Etat : New. Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease. Book. N° de réf. du vendeur BBS-9783540539490
Quantité disponible : 5 disponible(s)
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9783540539490
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 20185366
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Following the major breakthroughs in the and frequent and thorough exchange of treatment of acute leukemias in the seven information. Hence, it was felt that a spe ties by the introduction of intensive combi cial series of symposia should be devoted to nation regimens, therapeutic progress has 'Pharmacokinetics and Management of slowed down and the impression of stagna Relapsed and Refractory Disease' comple menting the established meetings on 'Prog tion may even have occured. In contrast, the knowledge about the biology of leu nostic Factors and Treatment Strategies' kemias is rapidly expanding and allows new which will proceed in parallel. It was the insights into the pathophysiology of the aim of the international symposium disease. Further improvements also come 'ACUTE LEUKEMIAS - Pharmacokine from a better understanding of the pharma tics and Management of Relapsed and cokinetics and pharmacodynamics of cyto Refractory Disease' to provide an update static drugs and their mechanisms of action. of the present knowledge in this area and to Hence, novel treatment modalities can be stimulate further developments. As a sign developed on a more solid basis and ration for the closing distance between countries al. These achievements need to be comple and the development of effective world mented by effective eradiation wide cooperation this symposium emerged of residual disease or its permanent control and new from the joint efforts of the German AML approaches have been derived from recent Cooperative Group and the M. D. 700 pp. Englisch. N° de réf. du vendeur 9783540539490
Quantité disponible : 2 disponible(s)
Vendeur : Chiron Media, Wallingford, Royaume-Uni
PF. Etat : New. N° de réf. du vendeur 6666-IUK-9783540539490
Quantité disponible : 10 disponible(s)
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 20185366-n
Quantité disponible : Plus de 20 disponibles
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In English. N° de réf. du vendeur ria9783540539490_new
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 20185366
Quantité disponible : Plus de 20 disponibles
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Drug Resistance in Leukemia.- Multidrug Resistance and Its Circumvention in Acute Leukemia.- The Role of DNA Topoisomerase II in Multidrug Resistance in Human Leukemia.- Development of Sensitive Assays to Detect Antifolate Resistance in Leukemia Blasts.- Se. N° de réf. du vendeur 4892993
Quantité disponible : Plus de 20 disponibles